Article Sidebar
Views PDF: 137
THE CLINICAL FEATURES OF COATS DISEASE
Main Article Content
Abstract
Objectives: Describe clinical and paraclinical features of Coats disease. Materials and Methods: A cross-sectional retrospective study on 32 eyes of 31 patients diagnosed with Coats disease at National Geriatric Hospital. Patients in the study had a clinical examination, fundus fluorescein Angiography, and optical coherence tomography. All patients in the study were collected clinical and subclinical data through medical records and retinal images. Results: The majority of patients from 4 to 20 years old accounted for 62,5%; Males account for more than females with 78.1%. Most patients had Coats disease in one eye and decreased visual acuity. There are 11 eyes with leukocoria, accounting for 34.4%. All patients had subretinal exudation, telangiectasia, light bulb aneurysms, and macular edema. On fundus angiography, 100% of eyes have telangiectasia, light bulb aneurysms, and retinal non-perfusion areas. On OCT scan. 100% of eyes have subretinal exudation and macular edema, and 6,7% have a retinal detachment. Conclusions: Coats disease has many symptoms, mainly decreased visual acuity, leukocoria, subretinal exudation, telangiectasia, light bulb aneurysms, and macular edema.
Article Details
Keywords
Coats, exudation, telangiectasia
References
2. Shields C, Udyaver S, Dalvin L, et al. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center. Indian journal of ophthalmology. 2019; 67(6):772.
3. Sen M, Shields CL, Honavar SG, Shields JA. Coats disease: An overview of classification, management and outcomes. Indian journal of ophthalmology. Jun 2019;67(6):763-771.
4. Ramasubramanian A, Shields CL. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. British Journal of Ophthalmology. 2012; 96(3):356-359.
5. Yousef YA, ElRimawi AH, Nazzal RM, et al. Coats’ disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease. Medicine. 2020;99(16):e19623.
6. Shields CL, Udyaver S, Dalvin LA, et al. Visual acuity outcomes in Coats disease by classification stage in 160 patients. British Journal of Ophthalmology. 2020;104(3):422-431.
7. Kang HG, Kim JD, Choi EY, et al. Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats’ disease in Korea. Scientific Reports. 2021;11(1).
8. Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. May 2001; 131(5):561-571.